Are you attending this year’s SCDM annual conference? Visit MMS at booth #313.
The SCDM Annual Conference is world-renowned for advancing the industry, revealing new ideas and growing the network of everyone who attends. It’s what makes it the Festival Of Opportunity.
Packed with potential, this year’s conference will reveal new ideas, powerful new technology, world-class guest speakers and key presentations on topics ranging from CDS & Analytics to AI & cognitive tech.
Join the global clinical data management community to discover how to drive data integrity, increase patient safety, direct the future of clinical data science – and enjoy every moment.
Schedule A Meeting Now
Please share your details to schedule a meeting with MMS representatives at this event, and let’s explore a future where accuracy, innovation, and unparalleled expertise drive your success.
Suggested For You
webinar
October 22nd, 2024
Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules
perspectives
September 30th, 2024
Meet the Leaders Driving MMS’s European Growth
perspectives
September 30th, 2024
The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry
perspectives
September 24th, 2024
Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry
perspectives
September 11th, 2024
From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs
webinar
September 26th, 2024
Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance
perspectives
September 4th, 2024
Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders
perspectives
August 27th, 2024
Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs
regulatory intelligence
August 27th, 2024
Recent Guidance on Diversity Action Planning
regulatory intelligence
August 26th, 2024
Oncology Programs at the FDA
regulatory intelligence
August 26th, 2024
Three Key Take Reflections on the Recent Donanemab Approval
perspectives
August 20th, 2024
Clinical Study Protocols: A Comprehensive Guide to Best Practices From A Senior Medical Writer